Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dyadic InternationalDYAI -1.87%39 12-1 Month Momentum % is -15.47% as of Aug. 01, 2026. GuruFocus rates DYAI with a GF Score™ of 39/100 and a GF Value™ of $0.74 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,358 Biotechnology companies, Dyadic International ranks worse than 53.24% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-08-01), Dyadic International's 12-1 Month Momentum % is -15.47%.
The industry rank for Dyadic International's 12-1 Month Momentum % or its related term are showing as below:
DYAI's 12-1 Month Momentum % is ranked worse than 53.24% of 1358
companies
in the Biotechnology industry
Industry Median: -17.575
vs DYAI: -15.47
Dyadic International (NAS:DYAI) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Dyadic International 12-1 Month Momentum % Related Terms
DYAI vs EXOZ, INMB, FLNA: 12-1 Month Momentum % Comparison
For the Biotechnology subindustry, Dyadic International's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dyadic International 12-1 Month Momentum % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Dyadic International's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Dyadic International's 12-1 Month Momentum % falls into.
Dyadic International (NAS:DYAI) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a 12-1 Month Momentum % of -15.47% mean?
Dyadic International (DYAI) has a 12-1 Month Momentum % of -15.47% as of Aug. 01, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Dyadic International and its competitors. According to the industry distribution chart, Dyadic International ranks #723 out of 1358 companies in the Biotechnology industry, placing it in the top 53.2%.
Is Dyadic International's 12-1 Month Momentum % too high?
Dyadic International's current 12-1 Month Momentum % is -15.47%. Based on the distribution chart, Dyadic International ranks #723 out of 1358 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Dyadic International has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dyadic International's 12-1 Month Momentum % compare to EXOZ and INMB?
According to the Biotechnology industry distribution chart, Dyadic International ranks #723 out of 1358 companies for 12-1 Month Momentum %. This places Dyadic International in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Biotechnology company?
A good 12-1 Month Momentum % depends on the Biotechnology industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Dyadic International and its competitors. Dyadic International's current 12-1 Month Momentum % is -15.47%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dyadic International stock overvalued right now?
Based on GuruFocus' analysis, Dyadic International (DYAI) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.74, compared to a current price of $1.06 — trading 42.6% above its estimated fair value. The current 12-1 Month Momentum % is -15.47%. Dyadic International's overall GF Score™ is 39/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Dyadic International (DYAI), the current 12-1 Month Momentum % is -15.47% as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dyadic International (DYAI) Overvalued in 2026?
Based on GuruFocus' analysis, Dyadic International stock appears to be overvalued.
The current stock price of $1.06 is trading 42.6% above its estimated GF Value™ of $0.74.
GuruFocus considers Dyadic International to be Significantly Overvalued.
Key valuation signals for DYAI:
12-1 Month Momentum %: -15.47%
GF Value™: $0.74 vs. price of $1.06 (42.6% above fair value)
No single metric tells the full story. See the DYAI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
39GF Score
Get the complete analysis for DYAI
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DYAI has been successfully added to your 
